Skip to content

Risk Factors Associated With Binge Drinking Behaviors Among College Students

AlcoholPredict: Neuropsychology, Brain Imaging and Genetic Polymorphisms in Binge Drinking

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02794311
Acronym
AlcoolPredict
Enrollment
125
Registered
2016-06-09
Start date
2015-02-01
Completion date
2019-09-24
Last updated
2026-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Binge Drinking

Brief summary

The purpose of this study is to specify the psychological, cognitive, neuro-functional and genetic profile associated with binge drinker behaviors among young adults. Results will help identifying more precisely vulnerability factors associated with this pattern of alcohol consumption and guiding prevention efforts.

Detailed description

Binge drinking behavior is characterised by speed of drinking on a particular occasion, frequency of drunkenness during the most recent six month period, and the percentage of times getting drunk when drinking. The prevalence of weekly binge drinking among European Union drinkers in 2009 was reported to be 28% of the student population, and 33% among all young people aged 15-24. The consequences of this behavior are multiple and often dramatic, they include: academic failure, violent acts, rape, domestic or road accidents. The study aims to identify vulnerability factors associated with binge drinking. The protocol explores the psychological (personality), neuropsychological (executive functions, memory), genetic (snp polymorphisms) and neuro-anatomical (fMRI) patterns associated with binge drinking behavior.

Interventions

OTHERAlcoolpredict

psychological (personality), neuropsychological (executive functions, memory), genetic (snp polymorphisms) and neuro-anatomical (fMRI)

Sponsors

CHU de Reims
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

: * Males or females * Right-handed * Aged 18-25 years * Native French speaker, able to read French and complete study evaluations * Caucasian * Able to provide informed written and verbal consent

Exclusion criteria

* A significant general medical illness, including neurological disorders, mental retardation or head trauma * Depression, bipolar disorder, schizophrenia or schizoaffective disorder diagnostic according to DSM-IV * Handling of psychotropics substances * A sensorial impairment (visual and/or hearing) * Women who are pregnant * Contraindication to the use of MRI (pacemaker, metal in their body)

Design outcomes

Primary

MeasureTime frame
Neuropsychological test : Mini International Neuropsychiatric Interview (M.I.N.I)day 1
Neuropsychological test : Wisconsin Card Sorting Test (WCST)V2(3 weeks later)
Genetics tests (Single Nucleotide Polymorphism)V2(3 weeks later)
MRI - signal BOLD (" Blood Oxygen Level Dependant ").V3(up to 2 month)
Neuropsychological test : Family Informant Schedule and Criteria (FISC)day 1
Neuropsychological test : Alcohol Use Questionnaireday 1
Neuropsychological test :Trail Making Test, partie A et BV3(up to 2 month)
Neuropsychological test : Plus/Minus TestV3(up to 2 month)
Neuropsychological test :Go/No-GoV3(up to 2 month)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026